Perils at mucosal front lines for HIV and SIV and their hosts. - Wikidata - awgldk - TriplyDB

Perils at mucosal front lines for HIV and SIV and their hosts.

Perils at mucosal front lines for HIV and SIV and their hosts.

http://www.wikidata.org/entity/Q36274922

about

Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells Catalytic antibodies to HIV: physiological role and potential clinical utility How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Challenges in mucosal HIV vaccine development: lessons from non-human primate models Microbicides: a new hope for HIV prevention Contribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus.Electron tomography of HIV-1 infection in gut-associated lymphoid tissue Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV Functional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIV Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination Glycans, galectins, and HIV-1 infection Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir Dendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitors Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development HIV/AIDS epidemiology, pathogenesis, prevention, and treatment Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.Biological factors that may contribute to regional and racial disparities in HIV prevalence.In vivo optical imaging of human vaginal gel thickness distributions with a probe-based, dual-modality instrument.Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses Quantitative 3D video microscopy of HIV transfer across T cell virological synapses Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.Resistance to simian immunodeficiency virus low dose rectal challenge is associated with higher constitutive TRIM5α expression in PBMC Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability.Going wild: lessons from naturally occurring T-lymphotropic lentiviruses Interferon regulatory factor 1 polymorphisms previously associated with reduced HIV susceptibility have no effect on HIV disease progression.Which topical microbicides for blocking HIV-1 transmission will work in the real world?Time scales of CD4+ T cell depletion in HIV infection.Semen may harbor HIV despite effective HAART: another piece in the puzzle HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection?High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells.Development of topical microbicides to prevent the sexual transmission of HIV PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection

P2860

Q21562543-D96AF48A-11EB-4D29-BCFA-14DFD8E32AC7 Q22241377-22CF73F7-768C-49C3-99D6-AC74C9A46E59 Q22251066-EDDFD368-5586-422F-99E5-2EA2D4BC3B94 Q24655912-A3F18CBD-094E-40FF-A4C9-CC49E885A6EC Q25257230-45E5EC8E-6618-48F4-8323-F9B63D5E5923 Q26779142-7C388883-A23B-49E7-98A6-F1488FDFDDF2 Q27010312-0B4B2B0B-29FC-4F4D-8DD9-484594DE3ADA Q27022152-2223869C-42CD-4620-A435-FFE9CB350B7F Q27022779-E58811F0-6A98-413A-8C05-30A231C18A76 Q27309008-DDC93515-5858-4478-B68D-9DEFA5AE79A5 Q27331060-BEA8CAD2-29C7-4692-87B6-B1F1E75FC854 Q27488278-B94FFAE6-771E-4159-ADF3-723D817EFDB2 Q27497560-B0D0E6BE-A66A-4A83-81A0-10910480497D Q27681527-A946ABF2-F219-4212-BE0B-0AEDE3D2F338 Q28081492-C9FC850E-4FBE-49FE-BFF2-100304200EF4 Q28265115-DBA7BEBF-D794-4D0B-8D58-58CCD7D0E715 Q28472146-10DDAEA6-B814-42F4-97E1-77D4AAD0F102 Q28534580-F7F4F99A-87B0-499D-A29E-F5DC76D76983 Q28730050-9B0C2D8E-FF88-47A8-8A7D-AC5126A01DCC Q30355260-173DEFFE-95DD-4D04-A3F2-F10ABFCAE231 Q30356074-CFDF884D-24CE-4830-A2BB-62C95CFD5B75 Q30359545-1E9A83DB-0302-46D6-9F39-A57E8B229B72 Q30375160-81C7823B-0F80-405C-8768-2596F8E12736 Q30398456-48B5E053-37D7-4788-8E9C-7EB37FC1A78C Q30447776-9B7210D5-4F9D-46D8-9B11-FFB7B644BA17 Q30487819-7F6943A4-AD7C-458E-BEBB-562298181FFE Q30490761-8AD2A2D4-7B49-4761-A889-A485D97296D3 Q30499386-47343D40-0DD3-4412-8EDF-E225FE4D523C Q30579576-62A3CEA6-ED9A-4DC9-8C1A-0A382CD9C116 Q31044936-6CC82B71-291E-4526-95EB-845897975104 Q31066870-C478BF4A-894D-4BFE-830A-AD98960DA7E3 Q31120821-A581F273-6AC5-435D-9A01-530E5BA83F71 Q33253661-C80A7060-D618-4F93-8B9A-150E37C58847 Q33285395-366101A6-2DF8-4705-9B1C-561B0DAC2C98 Q33349099-A3DF1941-1CB2-477F-B75A-F0EAE2DB7E3B Q33366554-9F995A7E-1E2E-46A4-935A-C0AAEB68828B Q33582135-D77AB229-3BE7-4B64-8FEB-CB991FB6B3BF Q33591038-1C4204EA-4DE2-4230-BD14-58B3BB91D851 Q33625073-2FB92384-0BE2-44CC-8DE6-C11FC63374E4 Q33628817-493C1D32-3E37-480A-8260-339F153A5FB2

P2860

Perils at mucosal front lines for HIV and SIV and their hosts.

http://www.wikidata.org/entity/Q36274922

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Perils at mucosal front lines for HIV and SIV and their hosts.

@ast

Perils at mucosal front lines for HIV and SIV and their hosts.

@en

type

label

Perils at mucosal front lines for HIV and SIV and their hosts.

@ast

Perils at mucosal front lines for HIV and SIV and their hosts.

@en

prefLabel

Perils at mucosal front lines for HIV and SIV and their hosts.

@ast

Perils at mucosal front lines for HIV and SIV and their hosts.

@en

P1433

Q36274922-558F0853-44DB-4945-8A10-E9A5C54C4DA9

P1476

Q36274922-99CAC10C-6DAC-4477-88A5-961819EB471C

P2093

Q36274922-FADE3DCE-96D0-4995-BFDB-A82682243204

P2860

Q36274922-0205B5FF-4562-4AE0-AF1A-BD623B32DC8C

Q36274922-05521AE0-1FBB-4042-9064-A03886C88D6F

Q36274922-0575BE7F-DE44-47C2-8316-60377709347F

Q36274922-058CD07B-4C09-4DCB-B028-CFAD54CF21AC

Q36274922-05A3D4BD-310A-451A-9AFD-539A645C8726

Q36274922-0A3A4A21-BE11-48FA-BE52-1E79116D4923

Q36274922-0B3FFF04-5A9F-4C32-BF9A-5FA77DC80CD1

Q36274922-0CC318B8-BAB9-48E9-9682-764A43390C54

Q36274922-10F36E2B-AE38-4EE1-B815-4BA47F373BC3

Q36274922-13384EE0-6043-4212-A207-957177410331

P304

Q36274922-5E141505-DCBA-4AB5-8AE6-4738E7F80D13

P31

Q36274922-A47B9105-07C7-41F4-9FA9-E24160491B0A

P356

Q36274922-A416CEBF-6FFD-49B8-B7B8-1E478BB4FB79

P433

Q36274922-44120435-7F4F-41CD-9C08-B0F9AD8E577C

P478

Q36274922-FDC8145C-A0C3-4B85-BFE5-2DDFBD9E937D

P577

Q36274922-626459B5-F2D6-424A-90FC-5BAD416A17FF

P5875

Q36274922-15A7FEE0-777E-4EBD-B901-94007553BE16

P698

Q36274922-024E6BB9-D127-4A8F-A902-D2C73FA3E71B

P921

Q36274922-BF1A4A63-9385-4AC0-BA4D-DA9F1F3538D3

P356

P1433

Nature Reviews Immunology

P1476

Perils at mucosal front lines for HIV and SIV and their hosts.

@en

P2093

Ashley T Haase

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

Host-bacterial mutualism in the human intestine

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

P304

783-792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRI1706

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7565309

http://www.w3.org/2001/XMLSchema#string

P698

16200081

http://www.w3.org/2001/XMLSchema#string

P921